|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0020268,
umls-concept:C0030705,
umls-concept:C0035647,
umls-concept:C0038435,
umls-concept:C0178602,
umls-concept:C0205082,
umls-concept:C0242966,
umls-concept:C0332161,
umls-concept:C0392756,
umls-concept:C0524727,
umls-concept:C1257890,
umls-concept:C1274040
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-4-8
|
|
pubmed:abstractText |
Severe systemic inflammation with a vasodilatory syndrome occurs in about one third of all patients after cardiac surgery with cardiopulmonary bypass. Hydrocortisone has been used successfully to reverse vasodilation in septic patients. We evaluated if stress doses of hydrocortisone attenuate severe systemic inflammatory response syndrome in a predefined risk group of patients after cardiac surgery with cardiopulmonary bypass.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0090-3493
|
|
pubmed:author |
pubmed-author:BriegelJosefJ,
pubmed-author:FreyLorenzL,
pubmed-author:GoetzAlwin EAE,
pubmed-author:KilgerErichE,
pubmed-author:KnollAnetteA,
pubmed-author:LammPeterP,
pubmed-author:NagyAndreasA,
pubmed-author:PeterKlausK,
pubmed-author:ReuterDanielD,
pubmed-author:SchuetzAlbertA,
pubmed-author:WeisFlorianF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
31
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1068-74
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12682474-Aged,
pubmed-meshheading:12682474-Anti-Inflammatory Agents,
pubmed-meshheading:12682474-Cardiac Surgical Procedures,
pubmed-meshheading:12682474-Cardiopulmonary Bypass,
pubmed-meshheading:12682474-Female,
pubmed-meshheading:12682474-Humans,
pubmed-meshheading:12682474-Hydrocortisone,
pubmed-meshheading:12682474-Interleukin-6,
pubmed-meshheading:12682474-Lactic Acid,
pubmed-meshheading:12682474-Male,
pubmed-meshheading:12682474-Middle Aged,
pubmed-meshheading:12682474-Prospective Studies,
pubmed-meshheading:12682474-Risk Factors,
pubmed-meshheading:12682474-Systemic Inflammatory Response Syndrome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery.
|
|
pubmed:affiliation |
Department of Anesthesiology, University of Munich, Klinikum Grosshadern, Munich, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
